Mr. Wilton joined CHOP in 2025 after a 25-year career spanning the pharmaceutical, biotech and academic sectors, and has been instrumental in establishing a new team focused on driving innovation and commercialization across the enterprise. From building capabilities in entrepreneurship, to establishing new business models and strategic collaborations with industry, the Innovation Ventures team maximizes the potential impact that CHOP innovations have on child health globally. Throughout his career, Mr. Wilton has focused on building high-performing teams that operate at the cutting edge of science, raising over $500 million in capital to advance multiple first-in-kind treatments for rare diseases and cancer into the clinic. He fosters a culture of innovation, empowering staff to develop and implement transformative ideas.
